A phase II trial of brincidofovir in kidney transplant patients at high risk of BK virus associated diseases
Latest Information Update: 02 Mar 2016
Price :
$35 *
At a glance
- Drugs Brincidofovir (Primary)
- Indications Polyomavirus infections
- Focus Therapeutic Use
- 02 Mar 2016 Status changed from not stated to planning.
- 02 Mar 2016 New trial record